Home > Insider Trading > Filing (0001401708-20-000055)

Filing Details

Accession Number:: 0001401708-20-000055
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-11 16:18:04
Reporting Period:: 2020-03-09

Accepted Time:: 2020-03-11 16:18:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401708	Nanostring Technologies Inc	NSTG	Biological Products, (No Disgnostic Substances) (2836)	200094687

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1575739	Bradley R Gray	530 Fairview Avenue N Seattle WA 98109	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-03-09	10,002	$0.00	60,560	No	4	M	Direct
Common Stock	Disposition	2020-03-09	3,936	$31.39	56,624	No	4	F	Direct
Common Stock	Acquisiton	2020-03-09	6,924	$2.24	63,548	No	4	M	Direct
Common Stock	Acquisiton	2020-03-09	15,125	$2.24	78,673	No	4	M	Direct
Common Stock	Acquisiton	2020-03-09	20,000	$1.92	98,673	No	4	M	Direct
Common Stock	Disposition	2020-03-09	3,556	$30.68	95,117	No	4	S	Direct
Common Stock	Disposition	2020-03-09	34,019	$31.53	61,098	No	4	S	Direct
Common Stock	Disposition	2020-03-09	4,052	$32.96	57,046	No	4	S	Direct
Common Stock	Disposition	2020-03-09	422	$33.67	56,624	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2020-03-09	10,002	$0.00	10,002	$0.00
Common Stock	Stock Option (right to buy)	Disposition	2020-03-09	6,924	$2.24	6,924	$2.24
Common Stock	Stock Option (right to buy)	Disposition	2020-03-09	15,125	$2.24	15,125	$2.24
Common Stock	Stock Option (right to buy)	Disposition	2020-03-09	20,000	$1.92	20,000	$1.92

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		No	4	M	Direct
0	2020-06-29	No	4	M	Direct
0	2020-06-29	No	4	M	Direct
6,041	2022-02-28	No	4	M	Direct

Footnotes

Restricted stock units ("RSUs") convert into Common Stock on a one-for-one basis.
The reported shares were withheld to cover the reporting person's tax liability in connection with the vesting of RSUs. The shares were not issued to or sold by the reporting person.
The sales reported by Mr. Gray were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2019.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $32.30 to $33.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $33.31 to $34.08, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Each RSU represents a contingent right to receive one (1) share of Issuer's common stock.
1/3 of the RSUs vest on the first market trading day following the first anniversary of March 6, 2017 (the "RSU Vesting Commencement Date"), and 1/3 of the RSUs vest annually each year on the first market trading day after the second and third anniversary of the RSU Vesting Commencement Date, in each case, subject to Participant's continuing to be a Service Provider (as defined in the 2013 Equity Incentive Plan) through each such date.
The option is subject to an early exercise provision and is immediately exercisable. 25% of the shares subject to the Option vest on the one year anniversary of June 25, 2010 (the "Vesting Commencement Date"), and thereafter 1/48th of the shares subject to the Option vest on each monthly anniversary of the Vesting Commencement Date.
The option is subject to an early exercise provision and is immediately exercisable. The Option vests as to 50% upon the "tools" portion of the Issuer's business becoming profitable, and the remaining 50% upon the FDA's final approval of Prosigna.
The option is subject to an early exercise provision and is immediately exercisable. 15% of the shares subject to the Option vested on March 1, 2012 (the "Vesting Commencement Date"), and thereafter 1/48th of the remaining shares subject to the Option vest on each monthly anniversary of the Commencement Date.